<DOC>
	<DOC>NCT00162448</DOC>
	<brief_summary>Double-Blind, Randomized, Single-Dose Study to Evaluate the Atrial Selectivity and Safety of BMS-394136 in Subjects with Implanted Dual-Chamber Pacemakers or Defibrillators</brief_summary>
	<brief_title>A Phase I Study to Assess the Electrophysiologic Effects of BMS-394136 on the Atrium and Ventricle in Patients With Dual-Chamber Pacemakers or Defibrillators</brief_title>
	<detailed_description />
	<mesh_term>Heart Diseases</mesh_term>
	<criteria>Patients with dualchamber pacemakers or defibrillators Recent acute ischemic events Recent atrial or ventricular arrhythmias Uncompensated heart failure Amiodarone use within last year Women of childbearing potential QTc &lt;430 msec males QTc &lt;450 msec females</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>Patients requiring dual-chamber pacemakers or defibrillators</keyword>
</DOC>